Physician
Maalouf, Bassam
Maalouf, Bassam was paid $771K by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 96413, Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance — 27% of everything it billed.
33Billing provider infoMAALOUF, BASSAM
O FALLON, IL 62269
O FALLON, IL 62269
33aNPI1720173438assigned 10/04/2006
33bProvider typeHematology & Oncology Physician
28Total paid$771K
24GClaims41,231
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Illinois
Rank by total paid#2 of 285
Median peer was paid$31K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,966 | $48K | |
| 2019 | 5,978 | $108K | |
| 2020 | 7,081 | $128K | |
| 2021 | 6,691 | $152K | |
| 2022 | 7,367 | $133K | |
| 2023 | 6,968 | $118K | |
| 2024incomplete | 4,180 | $83K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 27% | 4,332 | 1,514 | $209K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 6,797 | 4,670 | $208K |
| 96375 | Therapeutic injection; each additional sequential IV push | 6.7% | 2,879 | 1,011 | $52K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 6.2% | 569 | 216 | $48K |
| 96367 | 5.9% | 1,940 | 659 | $46K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.9% | 1,643 | 1,511 | $30K |
| 80053 | Comprehensive metabolic panel | 3.7% | 2,859 | 2,119 | $29K |
| J1453 | Injection, fosaprepitant, 1 mg | 3.1% | 120 | 51 | $24K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 2,069 | 906 | $14K |
| 85027 | 1.7% | 2,277 | 1,677 | $13K | |
| 96417 | 1.6% | 361 | 114 | $12K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.4% | 166 | 166 | $11K |
25 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.2% | 384 | $9K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 1,622 | $9K |
| 85007 | 1.0% | 2,251 | $8K | |
| 83615 | <1% | 1,346 | $7K | |
| 83735 | <1% | 852 | $5K | |
| 83550 | <1% | 626 | $5K | |
| 82728 | <1% | 641 | $5K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 123 | $5K |
| 83540 | <1% | 627 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 174 | $3K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 229 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,226 | $2K |
| 82607 | <1% | 171 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 905 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,343 | $1K |
| 82746 | <1% | 97 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 27 | $981.15 |
| 96415 | <1% | 36 | $821.73 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 14 | $231.52 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 53 | $179.41 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 188 | $147.02 |
| J3490 | Unclassified drugs | <1% | 232 | $87.56 |
| 85045 | <1% | 27 | $67.32 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 12 | $0.00 |
| 99441 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.